Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.10
-0.10 (-0.22%)
At close: Mar 27, 2026
Market Cap1.89B +16.5%
Revenue (ttm)220.40M +128.2%
Net Income58.93M
EPS1.40
Shares Out42.00M
PE Ratio32.21
Forward PEn/a
Dividend1.00 (2.22%)
Ex-Dividend DateApr 9, 2026
Volume121,509
Average Volume143,358
Open45.20
Previous Close45.20
Day's Range44.15 - 46.45
52-Week Range29.65 - 80.40
Beta0.73
RSI58.72
Earnings DateMay 5, 2026

About Taiwan Biomaterial

Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan. It offers Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO. The company was founded in 1921 and is based in Zhubei, Taiwan. [Read more]

Sector Healthcare
Founded 1921
Employees 35
Stock Exchange Taipei Exchange
Ticker Symbol 6649
Full Company Profile

Financial Performance

Financial Statements